Murali Badanthadka

Dr. Murali Badanthadka


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
PDF file
MBMurali Badanthadka
Murali Badanthadka
LDLidwin D'SOuza
Lidwin D'SOuza
Psoriasis is an autoimmune, inflammatory skin disease known to lead by the combination of genetic and environmental factors. Globally it affects around 2–3% of the population, which significantly affect the quality of life of the people because of its chronic nature and financial burden. The disease develops as the consequence of the complex interplay between the immune system, epidermal keratinocytes, and other APCs. The lack of a suitable model vastly hindered the research in psoriasis. Over the years, developed number of animal models, but none of them were proved to be completely mimic the phenotype and mechanism supports the disease progression. IMQ is used for the treatment of neoplastic and viral skin diseases, including perianal and genital warts, actinic keratosis, and superficial basal cell carcinoma. However, repeated application of IMQ leads to psoriasiform dermatitis by the activation of toll-like receptor 7/8, which accelerates to the release of inflammatory cytokines by the involved mechanisms. Although many preclinical models are available for the screening of antipsoriatic agents, IMQ-induced psoriasis has been considered as an easy, convenient, immunologically clean animal model. Over the years, the utilization of this model is significantly increased. There also exist some limitations which cannot be over looked. Attentive contemplations are necessary for the interpretation of the results obtained by employing this model. In this review, we provided an insight into the IMQ-induced psoriasis mice model.

14 May 2021 in Journal of Health and Allied Sciences NU
Verified
Journal Article
Open access
PDF file
FSFathima Salwa
Fathima Salwa
MBMurali Badanthadka
Murali Badanthadka
LDLidwin D’sOuza
Lidwin D’sOuza
Introduction The influence of animal strain on psoriasis model development by imiquimod (IMQ) has been studied in Balb/c and Swiss mice. Materials and Methods Female mice of either strain were challenged with 5% IMQ (62.5 mg on back skin, 10 mg on right ear). They were observed for the severity of the disease using Psoriasis area severity index (PASI), splenomegaly, and histopathological alterations. To validate the model, well-established antipsoriatic drug clobetasol (0.05%, 120 mg on the back skin, 10 mg on the right ear) was used. Additionally, to study the strain-dependent response to IMQ associated with oxidative stress, various antioxidant factors like superoxide dismutase (SOD), catalase (CT), and glutathione (GSH) were measured. Antioxidant natural product curcumin (1%, 150 mg on back skin, 12.5 mg on right ear) was used to evaluate the alleviation of oxidative stress on distinct mice strain. Results PASI score, body weight, and histopathology indicated the development of disease in both the strains, severity, and stability of which was dependent on the particular strain. Splenomegaly suggested the systemic effect, which was comparable in both the stains. IMQ and its involvement in redox status were confirmed by an alteration in the activity of SOD, CT, and levels of GSH. Conclusion This study demonstrated that, in the IMQ-induced psoriasis model, the genetic background has some impact on the disease severity, stability, and redox imbalance.

18 November 2022 in Journal of Pharmacological and Toxicological Methods
Verified
Journal Article
Closed access
MRMadhura R.J.
Madhura R.J.
VAVarsha A.
Varsha A.
ACAnirban Chakraborthy
Anirban Chakraborthy
MBMohana Kumar B.
Mohana Kumar B.
VAVeena Shetty A.
Veena Shetty A.
MBMurali Badanthadka
Murali Badanthadka

20 January 2022 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
VSVinitha D Souza
Vinitha D Souza
MSMeghashree Shetty
Meghashree Shetty
MBMurali Badanthadka
Murali Badanthadka
BMB.S. Mamatha
B.S. Mamatha
KVK. Vijayanarayana
K. Vijayanarayana

5 December 2022 in Journal of Health and Allied Sciences NU
Verified
Journal Article
Open access
PDF file
VDVinitha D'SOuza
Vinitha D'SOuza
MRMadhura Rj
Madhura Rj
MSMeghashree Shetty
Meghashree Shetty
VAVarsha A.
Varsha A.
ACAnirban Chakraborthy
Anirban Chakraborthy
MBMurali Badanthadka
Murali Badanthadka
Objectives The study aims to develop a stable malnourished experimental mice model resembling the human population for future experimental studies. Materials and Methodology At weaning, female BALB/c mice are separated into two groups: one receiving a low protein diet (LPD, 10% protein) and the other receiving a commercially available normal pellet diet (ND, 18% protein). Model development and stability were assessed using body mass index (BMI), biochemical parameters such as glucose, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, total protein, albumin, total cholesterol, calcium, and phosphorus using serum samples at the 12th and 15th weeks of the study, antioxidant assay, and liver histopathology observation. Antioxidant assay and histopathology observation using liver tissue sample excised after euthanasia. Results LPD mice are categorized under grade I malnutrition based on the body weight change with respect to ND as per the principles of Gomez's classification of malnutrition. A significant long-term decrease in BMI of the malnourished group indicates the development of the stable malnourished model. Elevated serum enzyme levels in the 15th week and decreased antioxidant activity suggest liver injury and oxidative stress at the cellular level in the malnourished group. Histopathology alterations in the liver tissue further strengthen these observations reported in the human population of malnutrition. Conclusion This study confirms the development of a stable malnourished experimental model using a LPD (10% protein). This model may be used to study the role of malnutrition in the pathophysiology of any disease, drug action, and its kinetics in the future.

25 December 2023 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
MBMurali Badanthadka
Murali Badanthadka
VDVinitha Dsouza
Vinitha Dsouza
MSMeghashree Shetty
Meghashree Shetty
VAVarsha A.
Varsha A.
MRMadhura R.J.
Madhura R.J.
VKVijayanarayana Kunhikatta
Vijayanarayana Kunhikatta
Objectives: Literature suggests that a high-fat diet (HFD) potentially increases the risk of chemical/drug-induced toxicity after an acute overdose. Drug/chemical-induced hepatotoxicity has been well studied, and the mechanism that regulates this toxicity has been extensively examined using different experimental animal models. Our study focuses on drug-induced hepatotoxicity in HFD-fed female Balb/C mice. This study addresses the effect of nutrition on the magnitude of acetaminophen (APAP)-induced hepatotoxicity at different time intervals. Materials and Methods: Female Balb/C mice, after the weaning period separated into two different groups, normal diet (ND) and HFD receiving groups; after 15 weeks, they were dosed with a single dose (300 mg/kg per os ( p.o. ) of APAP. Blood samples were collected at different time intervals (0, 6 and 24 hours), and liver samples were collected at the end time point. Liver injury parameters [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)], antioxidant assay (sodium dismutase, glutathione, and catalase), and histopathology study were conducted. Pharmacokinetic (PK) analysis was done using the RP-HPLC system and Phoenix WinNonlin 8.3 software. Results: APAP-induced liver injury decreased AST and ALT in the HFD group compared with the ND group at 6 and 24 hours (p p < 0.01 and p < 0.001), respectively. Antioxidant enzyme levels remained constant in the HFD group, whereas histopathology showed remarkable changes. The PK's of APAP in HFD indicate lower plasma concentrations of APAP (p p < 0.05), with two-fold higher clearance and volume of distribution. Conclusion: HFD significantly reduced susceptibility to APAP-mediated liver injury in Balb/C mice compared with ND mice. Our study mimics the clinical scenario where the same dose of the drug is prescribed to the normal and obese population. Our results suggest the potential need for dose titration to assess an individual's nutritional state in a clinical scenario.